University of California Davis Comprehensive Cancer Center P2C — Sacramento, California

University of California Davis Comprehensive Cancer Center P2C is a clinical research site located in Sacramento, California, United States 95817.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California Davis Comprehensive Cancer Center P2C has participated in 1 clinical trials.

Therapeutic areas: Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland Hurthle Cell Carcinoma.

Sponsors: National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sacramento

Browse all research sites in California · View every site in Sacramento

• Northern California Veterans Affairs Healthcare System
• University of California Davis Cancer Center, Division of Hematology-Oncology
• University of California, Davis Department of Pediatrics
• University of California Davis Health System, Comprehensive Cancer Center
• University of California at Davis, CCRC
• University of California, David Clinical & Translational Science Center Clinical Research (CCRC)
• University of California
• University of Califoria, Davis
• VA Northern California HCS
• Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research
• UC DavisHealth Main Hospital
• Shriners Hospitals for Children

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Davis Comprehensive Cancer Center P2C?

University of California Davis Comprehensive Cancer Center P2C has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Davis Comprehensive Cancer Center P2C conducted?

University of California Davis Comprehensive Cancer Center P2C has 1 clinical trials on record. Their work covers Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland Hurthle Cell Carcinoma.

Is University of California Davis Comprehensive Cancer Center P2C accredited by Crixeo Clinical Trials?

University of California Davis Comprehensive Cancer Center P2C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Davis Comprehensive Cancer Center P2C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.